Actively Recruiting
Platelet Rich Plasma Testis Treatment for Infertile Men
Led by Stanford University · Updated on 2026-01-13
10
Participants Needed
1
Research Sites
206 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Investigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series suggest that intratesticular PRP injections may improve TESE outcomes. We hope to determine whether PRP is an effective treatment for this patient population.
CONDITIONS
Official Title
Platelet Rich Plasma Testis Treatment for Infertile Men
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men over the age of 18 diagnosed with nonobstructive azoospermia (NOA) and at least one failed TESE, negative mapping, or negative biopsy
You will not qualify if you...
- No exclusion criteria specified
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stanford Urology Clinic
Stanford, California, United States, 94304
Actively Recruiting
Research Team
S
Satvir Basran
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here